Application of 3DSlicer Technology in Percutaneous Nephrolithotomy Surgery.
The Application of 3DSlicer Technology in Percutaneous Nephrolithotomy Surgery.
1 other identifier
observational
105
1 country
1
Brief Summary
Objectives: Percutaneous nephrolithotomy (PCNL) has become a widely used technique for managing renal calculi. However, the rate of residual stones remains high. Accurate preoperative assessment of the individual's renal collecting system anatomy and strategic planning of access pathways are essential for improving stone-free outcomes. This study investigated whether characteristics of the target calyx can predict stone clearance through a distinct puncture calyx and developed a model to estimate the risk of residual stones in the target calyx. Methods: We performed a retrospective analysis of patients who underwent PCNL in the urology department of our center between January 2023 and June 2025, in whom the puncture calyx differed from the target calyx (67 cases with complete stone clearance and 38 cases with residual stones). Three-dimensional reconstructions of the renal collecting system and calculi were generated from preoperative urinary tract CT scans, and spatial parameters were obtained from these models. Patient and stone characteristics were combined with 3D-derived variables for binary logistic regression to identify predictive factors and construct nomograms. Model performance was assessed using receiver operating characteristic (ROC) and calibration curves, while clinical utility was evaluated through decision curve analysis (DCA). The Youden index was applied to determine the optimal cutoff value.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedFirst Submitted
Initial submission to the registry
December 10, 2025
CompletedFirst Posted
Study publicly available on registry
December 23, 2025
CompletedDecember 23, 2025
December 1, 2025
2.5 years
December 10, 2025
December 10, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
predict the stone free possibility of kidey stone
AUC curve
2023-2025
predict the stone free possibility of kidey stone
DCA curve
2023-2025
Study Arms (2)
Stone Free Group
Stone Residue Group
Eligibility Criteria
After applying these criteria, a total of 105 renal calyces were included for analysis
You may qualify if:
- ① preoperative diagnosis of renal calculi confirmed by computed tomography urography (CTU); ② completion of standard-channel (F24) PCNL with the puncture and target calyces situated in different renal calyces; and ③ postoperative CT imaging performed within one week after surgery.
You may not qualify if:
- ① anatomical abnormalities of the affected kidney, such as severe renal rotation or horseshoe kidney; and ② history of secondary procedures, including repeat PCNL or renal puncture with fistula formation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ting Huanglead
Study Sites (1)
Department of Urology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine,
Jinhua, Zhejiang, 321000, China
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 10, 2025
First Posted
December 23, 2025
Study Start
January 1, 2023
Primary Completion
June 30, 2025
Study Completion
June 30, 2025
Last Updated
December 23, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share